According to a letter sent to healthcare professionals, the marketing and distribution rights of EpiPen® (adrenaline in an auto-injector) have change to a different company, Meda Pharmaceuticals. This change is accompanied by a reduction in price of the product from £28.77 to 26.45.
In addition, the new distributor is working with the manufacturer to ensure consistent future supplies of this product and they have also launch a product website that offers an expiry date reminder service. This free service allows patients to register their details so they will receive an email and/or text message alert when their EpiPen is due to expire. These alerts are sent at 4 and 2 weeks prior to expiry and also on the day of expiry.
Action: Clinicians should be aware of the change of distributor and may wish to make patients aware of the expiry notification service.
|« Pulse challenges statin rationing||NICE Guidance - April 2011 »|